Raimar Löbenberg

Raimar Löbenberg

Fortune : 1 M $ au 30/06/2026

60 ans
Consumer Services
Health Technology
Commercial Services

Profil

Raimar Löbenberg is the founder of RS Therapeutics, Inc., founded in 2018, serving as Chief Scientific Officer since 2018.
Dr. Löbenberg is the founder of BioNxt Solutions, Inc., founded in 2017, serving as Independent Director since 2018.
Current jobs include Director-Drug Development & Innovation Center at the University of Alberta since 2000 and Co-Managing Director at Vektor Pharma TF GmbH.
Former jobs include Independent Chairman at Defence Therapeutics Inc and President of the Canadian Society for Pharmaceutical Sciences from 2014 to 2015.
Education includes a doctorate from Johann Wolfgang Goethe-Universität Frankfurt am Main and an undergraduate degree from The Johannes Gutenberg University of Mainz.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
29/09/2025 5 040 000 ( 3,88 % ) 1 M $ 30/06/2026

Postes actifs de Raimar Löbenberg

SociétésPosteDébut
BIONXT SOLUTIONS INC. Fondateur 12/12/2017
Corporate Officer/Principal 01/01/2000
RS Therapeutics, Inc.
Fondateur 01/11/2018
Directeur Général -

Anciens postes connus de Raimar Löbenberg

SociétésPosteFin
President 01/01/2015
DEFENCE THERAPEUTICS INC. Président -
Voir l'expérience en détail de Raimar Löbenberg

Formation de Raimar Löbenberg

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

86

Relations au 1er degré

8

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées8

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Health Technology

RS Therapeutics, Inc.

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Raimar Löbenberg
🔇